Cefpirome

Jump to: navigation, search
Cefpirome
Cefpirome.png
Clinical data
AHFS/Drugs.comInternational Drug Names
ATC code
Identifiers
CAS Number
PubChem CID
ChemSpider
UNII
KEGG
ChEMBL
E number{{#property:P628}}
ECHA InfoCard{{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value).
Chemical and physical data
FormulaC22H22N6O5S2
Molar mass514.58 g/mol
3D model (JSmol)
 ☒N☑Y (what is this?)  (verify)

WikiDoc Resources for Cefpirome

Articles

Most recent articles on Cefpirome

Most cited articles on Cefpirome

Review articles on Cefpirome

Articles on Cefpirome in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Cefpirome

Images of Cefpirome

Photos of Cefpirome

Podcasts & MP3s on Cefpirome

Videos on Cefpirome

Evidence Based Medicine

Cochrane Collaboration on Cefpirome

Bandolier on Cefpirome

TRIP on Cefpirome

Clinical Trials

Ongoing Trials on Cefpirome at Clinical Trials.gov

Trial results on Cefpirome

Clinical Trials on Cefpirome at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Cefpirome

NICE Guidance on Cefpirome

NHS PRODIGY Guidance

FDA on Cefpirome

CDC on Cefpirome

Books

Books on Cefpirome

News

Cefpirome in the news

Be alerted to news on Cefpirome

News trends on Cefpirome

Commentary

Blogs on Cefpirome

Definitions

Definitions of Cefpirome

Patient Resources / Community

Patient resources on Cefpirome

Discussion groups on Cefpirome

Patient Handouts on Cefpirome

Directions to Hospitals Treating Cefpirome

Risk calculators and risk factors for Cefpirome

Healthcare Provider Resources

Symptoms of Cefpirome

Causes & Risk Factors for Cefpirome

Diagnostic studies for Cefpirome

Treatment of Cefpirome

Continuing Medical Education (CME)

CME Programs on Cefpirome

International

Cefpirome en Espanol

Cefpirome en Francais

Business

Cefpirome in the Marketplace

Patents on Cefpirome

Experimental / Informatics

List of terms related to Cefpirome

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Cefpirome is a fourth-generation cephalosporin. Trade names include Cefrom, Keiten, Broact, and Cefir. Cefpirome is considered highly active against Gram-negative bacteria, including Pseudomonas aeruginosa, and Gram-positive bacteria.

Spectrum of bacterial susceptibility and resistance

Bacteroides fragilis, enterococci, Pseudomonas spp. and staphylococci are resistant to cefpirome sulfate, and some Haemophilus spp. and pneumococci have developed resistance to it to varying degrees.

References


Linked-in.jpg